ISO 14001 & ISO 45001 Certification Project Kick-off at PT Kalbio Global Medika
As an effort to comply with the international standards, especially in the field of Occupational Health, Safety, and Environment (OHSE), PT Kalbio Global Medika (KGM) is preparing to receive ISO 14001:2015 (Environmental Management System) and ISO 45001:2018 (Occupational Health and Safety Management System) certifications in this 2022.
Starting with the commitment signing by Mr. Nakkiran Saravanakumar as the Director of KGM on 28 April 2022, all management and employees are committed to supporting and making the certification a success.
With careful and thorough preparation, including the formation of an ISO team that represents all departments, it is hoped that the certification process is going to run smoothly so that the target in December 2022 can be achieved.
KGM at a Glance
Kalbio Global Medika (KGM) is one of the first and the pioneer of biopharmaceuticals in Indonesia, established in 2014 and inaugurated officially in 2018 by the President of the Republic of Indonesia, Ir. Joko Widodo. KGM is part of the Kalbe Group, a subsidiary of PT Kalbe Genexine Biologics (KGbio), which is a clinical-stage biotechnology company focused on bringing biologics medical innovation to markets outside US/Canada, Western Europe, and China. KGM is an Innovative CDMO, equipped with CMC and scale-up capabilities plugged into Boston biotech ecosystem and state-of-the-art facility to enhance efficiency and productivity. With API manufacturing, formulation, fill and finish capabilities of biosimilar and novel biologics, averaging 10 million units of syringes, cartridges, and vials, KGM supplies local and international markets.